Abstract:Aim: To improve a rat model for the proliferation of hepatic oval cells by Solt-Farber method and investigate the biological peculiarity and immunohistochemical localization of hepatic oval cells. Methods: The experiment was carried out in the Tongji Medical College, Huazhong University of Science and Technology between September 2004 and September 2005. 1 Grouping: A total of 120 male SD rats weighing 180 g were randomly allocated into 2-acetaminofluorene (AAF) treatment groups at 5 and 20 mg/kg, as well as control group, with 40 rats in each group. 2 Model establishment and administration: Solt-Farber method was modified: The rats of treatment groups received daily oral gavage of AAF for 3 days before operation and up to 7 days after operation. Before operation, AAF was given at the dosage of 20 mg/kg. After operation AAF was given at the dosage of 5 mg/kg and 20 mg/kg respectively. Two-thirds hepatectomy was performed on the 4th: day and the gavage was not administrated on the day of operation. Animals in control group were given saline. 3 Rats were killed every 3 days after hepatectomy, and liver slices were fixed and processed for routine histology and hematoxylin-eosin staining. Immunohistochemical staining was used to detect the proliferation and location of hepatic oval cells. Results: 1 The rats of AAF treatment groups present obvious hyperemia and blunt edge in liver tissues. From the 5th day post-operation on, needle pin-like tiny granules presented locally in the surface of liver, accompanying occasional hemorrhagic spots. 2 Hepatic oval cells were not observed in the liver of controls and obvious proliferation were seen in the liver of treatment groups, with no significant difference in quantity (P > 0.05). 3 Morphological characteristics of hepatic oval cells: Cell volume was equal to 1/4-1/3 of hepatic cells, moreover, cell body and volume were both uneven; Hepatic oval cells arranged in glandular tube-like, cluster or diffused distribution. 4 Hepatic oval cells were stained positively for OV6, CK19, c-kit, CD34, AFP. Conclusion: 1 Satisfactory rat models for hepatic oval cells proliferation can be obtained through adjusting the dosage of AAF. The proliferative oval cells posses differentiat ional potency by means of double direction. 2 Hepatic oval cells are located mainly at the binding areas or nearby areas of hepatic parenchymal cells and bile duct epithelial cells.

The Role Of P28(Gank) In Rat Oval Cells Activation And Proliferation

Gene and Protein Expressions of P28gank in Rat with Liver Regeneration.

Abnormal expression and clinical significance of Gankyrin during hepatocarcinogenesis in rats

Expression Of P28(Gank) And Its Correlation With Rb In Human Hepatocellular Carcinoma

P28gank Overexpression Accelerates Hepatocellular Carcinoma Invasiveness and Metastasis Via Phosphoinositol 3-Kinase/akt/hypoxia-inducible Factor-1Α Pathways.

P28^gank Inhibits Endoplasmic Reticulum Stress-Induced Cell Death Via Enhancement of the Endoplasmic Reticulum Adaptive Capacity

P28gank Prevents Degradation of Oct4 and Promotes Expansion of Tumor-Initiating Cells in Hepatocarcinogenesis

P-21 Activated Kinases in Liver Disorders

The oncoprotein p28 GANK establishes a positive feedback loop in β-catenin signaling

Establishment of Hepatic Oval Cell Proliferation Model and Purification of Hepatic Oval Cell

Characterization and Enrichment of Hepatic Progenitor Cells in Adult Rat Liver

Wnt/β‐Catenin Pathway is Critical in Hepatic Oval Cell Activation in Rats.

P28gank Knockdown-Derived Reactive Oxygen Species Induces Apoptosis Through Mitochondrial Dysfunction Mediated by P38 in Hepg2 Cells

A novel diagnostic marker, p28 GANK distinguishes hepatocellular carcinoma from potential mimics

Involvement of P21 and P27 in the Regulation of CDK Activity and Cell Cycle Progression in the Regenerating Liver.

Construction of Oncogene P28~(gank) Mutants and Their Regulating Effects on P53

Construction of oncogene p28GANK mutants and their regulating effects on p53

Reestablishment and immunohistochemical localization of rat models of hepatic oval cells

p28GANK monoclonal antibody and application thereof

Isolation, Culture and in Vitro Differentiation of Rat Oval Cells

Expression of Hepatocyte Growth Factor in a Rat Model of Obstructive Nephropathy and Implication